Releases
Found 38369 articles
Lincoln Educational Services Faces Securities Fraud Investigation
A 24.93% single-day stock plunge has triggered a formal investigation into Lincoln Educational Services Corp. by the Pomerantz Law Firm. The inquiry focuses on potential securities fraud and unlawful business practices following the company's disclosure of sluggish student enrollment growth during its second-quarter earnings report.
Shutterstock’s Alessandra Sala Named to 2026 TIME100 AI List
Dr. Alessandra Sala, Senior Director of AI and Data Science at Shutterstock, has earned a place on the 2026 TIME100 AI list. The recognition highlights her career-long pursuit of embedding ethics, transparency, and human-centric governance into the development of global artificial intelligence systems.
Pomerantz LLP Launches Investigation Into Emergent BioSolutions
A 29.58% single-day stock plunge has triggered a formal investigation into Emergent BioSolutions Inc. (NYSE: EBS) by the law firm Pomerantz LLP. The probe examines whether company leadership engaged in securities fraud or unlawful business practices following a sharp reduction in revenue guidance and a massive impairment charge.
Navigating Auto Insurance Claims After a Tennessee Collision
Drivers in Tennessee often face uncertainty immediately following a vehicle accident, struggling to balance insurance requirements with the need for quality repairs. Andy Spence, a collision repair expert based in Jackson, clarifies the process, emphasizing that motorists hold more control over their repair choices and claim outcomes than they realize.
Mosaic Declares Quarterly Dividend of $0.22 per Share
The Mosaic Company board of directors has authorized a quarterly dividend payment of $0.22 per share for its common stock. This distribution marks the latest financial return for shareholders, following a formal declaration made by the Tampa-based fertilizer producer during its most recent session on August 27.
Quaker Houghton Schedules Investor Day at NYSE for December
The New York Stock Exchange will host Quaker Houghton’s upcoming Investor Day on December 10, 2026, marking a strategic pivot for the global industrial process fluids leader. Management plans to outline long-term financial objectives and growth drivers during the morning session, which begins promptly at 8:30 a.m. Eastern time.
Pomerantz LLP Launches Investigation Into Klarna Following Stock Plunge
Klarna shareholders face a sharp financial reckoning after the fintech company slashed its full-year 2026 revenue forecast and announced the impending departure of its top financial and marketing executives. The sudden disclosure triggered a 22.81% collapse in the firm's share price, prompting a formal investigation by Pomerantz LLP.
FMC leadership to address Jefferies Global Industrials Conference
FMC Corporation executives Pierre Brondeau and Andrew Sandifer are set to present at the 2026 Jefferies Global Industrials Conference on September 10. The session, scheduled for 11:30 a.m. Eastern Time, will offer investors and industry analysts insight into the agricultural sciences company's strategic outlook and current market position.
Pomerantz Law Firm Probes L3Harris Following CEO Departure
The sudden resignation of L3Harris Technologies CEO Christopher Kubasik has triggered a formal investigation by Pomerantz LLP. The firm is examining potential securities fraud and fiduciary breaches after the company confirmed that Kubasik’s departure stemmed from conduct inconsistent with its internal code of ethics.
First US Bancshares Declares Quarterly Cash Dividend
Shareholders of First US Bancshares, Inc. are set to receive a cash dividend of $0.07 per share, following a decision by the company's Board of Directors. The payout is scheduled for October 1, 2026, for those on record as of the close of business on September 11, 2026.
Pomerantz LLP Launches Investigation Into Abeona Therapeutics
A 14.95% drop in Abeona Therapeutics stock on August 13, 2026, has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The firm is currently reviewing whether company leadership engaged in unlawful business practices following a disclosure regarding the revenue recognition of their ZEVASKYN therapy.
Pomerantz LLP Launches Investigation into Sionna Therapeutics After Stock Slump
A 91.18% collapse in Sionna Therapeutics’ share price has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The firm is currently reviewing whether company leadership misled investors regarding the clinical efficacy of its lead nucleotide binding domain 1 stabilizer programs.
Pomerantz Law Firm Launches Inquiry Into Azenta Stock Performance
Following the sudden resignation of Chief Executive Officer John Marotta, the Pomerantz Law Firm has initiated an investigation into Azenta, Inc. to determine if the company or its leadership engaged in securities fraud or unlawful business practices, potentially impacting shareholder value and corporate governance standards.
Pomerantz LLP Launches Investigation into Hims & Hers Health
A series of regulatory challenges and internal billing disputes has triggered a formal investigation by Pomerantz LLP into Hims & Hers Health. The firm is examining potential securities fraud and unlawful business practices following allegations regarding the company's handling of sensitive patient data and its subscription billing policies.
AirSculpt Technologies Faces Investor Investigation Following Stock Plunge
A 45% collapse in share price following disappointing second-quarter results has triggered a formal investigation into AirSculpt Technologies. New York-based Pomerantz LLP is currently examining whether the company or its leadership engaged in securities fraud or unlawful business practices, potentially opening the door for a class-action lawsuit.
Investors Eye Lead Plaintiff Role in Pentair Securities Litigation
Investors who purchased Pentair plc securities between April 28 and July 14, 2026, face an October 2 deadline to seek appointment as lead plaintiff in a pending class action lawsuit. The litigation alleges that the company misled shareholders regarding significant inventory destocking within its pool channel.
JLL Income Property Trust Purchases Tuscaloosa Retail Center for $94M
With over 5.7 million annual visits, Midtown Village in Tuscaloosa has become the latest acquisition for JLL Income Property Trust. The Chicago-based REIT finalized the purchase of the 345,000-square-foot open-air shopping center for approximately $94 million, citing the property's prime location and stable tenant base as key drivers.
Investors File Class Action Against Fractyl Health Over Revita Results
Pomerantz LLP has initiated a class action lawsuit against Fractyl Health, Inc. and its senior officers, alleging the company misled shareholders regarding the efficacy of its Revita DMR System. The litigation follows a sharp decline in share price triggered by disappointing clinical data released in early 2026.
Aardvark Therapeutics Faces Class Action Lawsuit Over IPO Disclosures
Investors have launched a class action lawsuit against Aardvark Therapeutics, alleging the biopharmaceutical company misled shareholders about the safety and commercial viability of its lead drug candidate, ARD-101. The complaint, filed in the Southern District of California, targets disclosures made during the company’s February 2025 initial public offering.
Investors Launch Class Action Against Wix Over AI Strategy Claims
A new class action lawsuit filed in the Northern District of Illinois alleges that Wix.com misled shareholders regarding the competitiveness and financial burden of its artificial intelligence initiatives. The complaint claims the company overstated the capabilities of its AI products while masking escalating development costs that pressured its stock price.
Pomerantz LLP Files Class Action Against EquipmentShare Over Fraud Claims
Investors who purchased EquipmentShare stock face a September 21 deadline to seek lead plaintiff status in a newly filed class action lawsuit. The litigation targets the company and its leadership following allegations of undisclosed related-party transactions and deceptive business practices that surfaced earlier this year.
Investors Face Deadline in GPGI Securities Fraud Class Action
Investors who suffered losses in GPGI, Inc. have until September 14, 2026, to seek appointment as lead plaintiff in a class action lawsuit filed by Pomerantz LLP. The litigation targets the company and its leadership over allegations of securities fraud and deceptive business practices during the past year.
Investors File Class Action Against Insulet Over Product Recalls
A class action lawsuit filed in the U.S. District Court for the District of Massachusetts alleges that Insulet Corporation misled shareholders regarding the safety and manufacturing integrity of its Omnipod insulin delivery systems. The litigation seeks to recover damages for investors who purchased stock during a period of recurring device corrections.
Hub Group Faces Class Action Over Financial Reporting Errors
Investors in Hub Group have until August 28, 2026, to seek lead plaintiff status in a class action lawsuit following the company's disclosure of material accounting misstatements. The litigation targets alleged securities fraud stemming from systemic failures in financial reporting that triggered significant drops in the firm's share price.
Hertz Investors Face Class Action After Liquidity and EBITDA Warning
Investors who purchased Hertz Global Holdings stock are facing a pivotal deadline as a class action lawsuit moves forward following the company's abrupt financial disclosure. The litigation centers on allegations of securities fraud, specifically questioning whether the firm misled shareholders regarding liquidity and its exposure to a softening used car market.
Regeneron Facing Class Action Lawsuit Following Clinical Trial Setbacks
Investors who suffered losses in Regeneron Pharmaceuticals are facing a September 14, 2026, deadline to seek appointment as lead plaintiff in a pending class action lawsuit. The litigation centers on allegations of securities fraud linked to the company’s disclosures regarding its Phase III Fianlimab-Libtayo clinical trial.
Photronics Investors Face Class Action Lawsuit Following Share Price Plunge
Investors who suffered losses in Photronics, Inc. have until September 4, 2026, to seek appointment as lead plaintiff in a class action lawsuit. The litigation targets the company and its leadership, alleging securities fraud following a sharp decline in financial performance and a subsequent 36.4% drop in share value.
Investors File Class Action Against Datavault AI Over Fraud Allegations
Pomerantz LLP has initiated a class action lawsuit against Datavault AI Inc. and its top executives, alleging the company misled shareholders through inflated partnership claims and by concealing the troubled pasts of key figures. The legal action follows a sharp decline in share price triggered by a critical report.
Intuit Faces Class Action Lawsuit Over Alleged Misleading Growth Claims
Pomerantz LLP has filed a class action lawsuit against Intuit Inc. and several top executives in the U.S. District Court for the Northern District of California. The litigation claims the company misled investors regarding its competitive standing and revenue growth targets during the 2026 fiscal year.
Investors Launch Class Action Suit Against Pentwater Capital
A federal class action lawsuit has been filed against Pentwater Capital Management and its CEO Matthew Halbower, alleging the firm orchestrated a massive market manipulation scheme involving Avis Budget Group. The litigation seeks to recover damages for investors who traded Avis securities during a period of extreme, artificial stock volatility.